NexImmune's Acquisition

NexImmune was acquired by Joshua Barer, Sol Barer and William Hawkins on February 14, 2017.

NexImmune is an early stage biopharmaceutical company developing immuno-therapeutics based on the Artificial IMmune (AIM) technology. The AIM technology provides an important advance in the developmen…

Articles about NexImmune's Acquisition: